Basis: Four-quarter operating cash flow / FMP quote market capitalization × 100. Source: stored company filings and market data; unavailable inputs remain N/A.
The operating cash flow yield is N/A as of 2026-10-06T14:55:50.207Z.
Calculation as of: 2026-10-06T14:55:50.207Z.
Quote observation: 2026-10-06T14:53:52.000Z. Amounts in USD. The price header may show a later quote.
FMP input reference: b8bc85e2d5351a47333dd9131f39a7cf6b6d5f02586c5202dd123a5ad4370615
Historical values estimate market capitalization from statement-period weighted shares. Comparisons with the current quote-based value are approximate. Only filing versions delivered by FMP are available for the historical calculation.
OPERATING CASH FLOW YIELD
N/A
Apyx Medical Corporation
Market Cap
$108.64M
Operating Cash Flow Yield
N/A
TTM Avg
N/A
3Y Avg
N/A
5Y Avg
N/A
Market Cap
$108.29M
Operating Cash Flow Yield
N/A
TTM Avg
N/A
3Y Avg
N/A
5Y Avg
N/A
Market Cap
$109.42M
Operating Cash Flow Yield
N/A
TTM Avg
N/A
3Y Avg
N/A
5Y Avg
N/A
Market Cap
$107.44M
Operating Cash Flow Yield
N/A
TTM Avg
12.54%
3Y Avg
12.54%
5Y Avg
12.54%
Market Cap
$107.28M
Operating Cash Flow Yield
0.70%
TTM Avg
8.27%
3Y Avg
16.31%
5Y Avg
18.05%
Market Cap
$110.05M
Operating Cash Flow Yield
N/A
TTM Avg
N/A
3Y Avg
N/A
5Y Avg
N/A
Market Cap
$105.48M
Operating Cash Flow Yield
39.27%
TTM Avg
38.13%
3Y Avg
19.19%
5Y Avg
12.42%
| NAME | MARKET CAP | OPERATING CASH FLOW YIELD | TTM | 3Y | 5Y |
|---|---|---|---|---|---|
| Apyx Medical Corporation (APYX) | $108.64M | N/A | N/A | N/A | N/A |
| Corbus Pharmaceuticals Holdings, Inc. (CRBP)vs › | $108.29M | N/A | N/A | N/A | N/A |
| Aardvark Therapeutics, Inc. Common Stock (AARD)vs › | $109.42M | N/A | N/A | N/A | N/A |
| Immunic, Inc. (IMUX)vs › | $107.75M | N/A | N/A | N/A | N/A |
| Black Diamond Therapeutics, Inc. (BDTX)vs › | $107.44M | N/A | 12.54% | 12.54% | 12.54% |
| Cumberland Pharmaceuticals Inc. (CPIX)vs › | $107.28M | 0.70% | 8.27% | 16.31% | 18.05% |
| Outlook Therapeutics, Inc. (OTLK)vs › | $110.05M | N/A | N/A | N/A | N/A |
| BGM Group Ltd. (BGM)vs › | $111.14M | N/A | N/A | N/A | N/A |
| Definitive Healthcare Corp. (DH)vs › | $105.48M | 39.27% | 38.13% | 19.19% | 12.42% |
| Coya Therapeutics, Inc. (COYA)vs › | $113.30M | N/A | N/A | N/A | N/A |
OCF Yield = TTM Operating Cash Flow / Market Cap
Operating cash flow yield is the inverse of P/OCF, expressing trailing operating cash flow as a percentage of price. It sits between earnings yield (before non-cash accrual effects) and FCF yield (before capital expenditure).
Expanded definitions: Investopedia, Wikipedia, Corporate Finance Institute
